Umbelliprenin

CAS No. 23838-17-7

Umbelliprenin( —— )

Catalog No. M24098 CAS No. 23838-17-7

Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 133 In Stock
10MG 195 In Stock
25MG 327 In Stock
50MG 484 In Stock
100MG 701 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Umbelliprenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.
  • Description
    Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL-6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23838-17-7
  • Formula Weight
    366.49
  • Molecular Formula
    C24H30O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 5 mg/ml (13.64 mM); DMF: 30 mg/ml (81.85 mM)
  • SMILES
    CC(C)=CCC/C(/C)=C/CC/C(/C)=C/COc(cc1)cc(O2)c1C=CC2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shahraki J, et al. Umbelliprenin relieves paclitaxel-induced neuropathy. J Pharm Pharmacol. 2020 Dec;72(12):1822-1829.
molnova catalog
related products
  • Guselkumab

    Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.

  • Kaempferitrin

    Kaempferitrin has antidepressant-like effect related to the serotonergic system, principally 5-HT1A.

  • Desacetyl asperulosi...

    Deacetylasperulosidic acid is a natural compound of Morinda citrifolia fruit. It has antioxidant activity by increasing superoxide dismutase activity. It also prevents 4-nitroquinoline 1-oxide (4NQO) induced DNA damage in vitro suppresses IL-2 production along with the activation of natural killer cells.